AVIDEX

Welcome to the Brand page for “AVIDEX”, which is offered here for Antibodies, proteins, t cell proteins and peptides for medical use, monoclonal antibodies for medical use; pharmaceutical and biochemical substances and preparations, small molecules, cd8o antagonists for the treatment of cancer and auto-immune diseases in vivo immunotherapeutic, inimunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use vaccines; protein conjugates for the treatment of cancer and auto-immune diseases diagnostic and analytical preparations for medical and veterinary use, products that diagnose and analyze the effects of cancer and tissue damage caused by inflammation due to auto-immune diseases; gene therapy and cell therapy products, t-cell receptors-- enzymes and enzyme preparations for medical purposes for the treatment of cancer and auto-immune diseases for clinical or medical use; chemical products for use in medical science, t-cell receptors small molecules and protein therapeutics for clinical or medical use, pre-filled vials containing pharmaceuticals and bioceuticals, small molecules and protein therapeutics involving t-cell receptors for the treatment of cancer and auto-immune diseases;apparatus and instruments for diagnostic and therapeutic research, instruments for measuring the spread of cancerous tissue, tissue damage or movement into affected limbs or organs; display apparatus, multi-well plates and arrays for medical and clinical diagnosis and analysis; surgical and medical apparatus and instruments, injectors for medical purposes, medical and surgical syringes;biotechnology services, research and development in biotechnology, product research and development for others in the field of biotechnology; scientific and medical research and development for others in the field of biotechnology and genomics, pharmaceutical drug development services and pharmaceutical product development; genetic engineering services, licensing intellectual property including trademarks and patents in the field of biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “AVIDEX” is believed to be currently owned by “MEDIGENE LIMITED”.